Your browser doesn't support javascript.
loading
The TIRS trial: Enrollment procedures and baseline characterization of a pediatric cohort to quantify the epidemiologic impact of targeted indoor residual spraying on Aedes-borne viruses in Merida, Mexico.
Earnest, James T; Kirstein, Oscar D; Mendoza, Azael C; Barrera-Fuentes, Gloria A; Puerta-Guardo, Henry; Parra-Cardeña, Manuel; Yam-Trujillo, Kevin; Collins, Matthew H; Pavia-Ruz, Norma; Ayora-Talavera, Guadalupe; Gonzalez-Olvera, Gabriela; Medina-Barreiro, Anuar; Bibiano-Marin, Wilberth; Lenhart, Audrey; Halloran, M Elizabeth; Longini, Ira; Dean, Natalie; Waller, Lance A; Crisp, Amy M; Correa-Morales, Fabian; Palacio-Vargas, Jorge; Granja-Perez, Pilar; Villanueva, Salha; Delfin-Gonzalez, Hugo; Gomez-Dantes, Hector; Manrique-Saide, Pablo; Vazquez-Prokopec, Gonzalo M.
Afiliación
  • Earnest JT; Department of Environmental Sciences, Emory University, Atlanta, GA, United States of America.
  • Kirstein OD; Central Laboratory of Entomology and Parasitology, Ministry of Health, Jerusalem, Israel.
  • Mendoza AC; Unidad Colaborativa para Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
  • Barrera-Fuentes GA; Unidad Colaborativa para Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
  • Puerta-Guardo H; Laboratorio de Hematología, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
  • Parra-Cardeña M; Unidad Colaborativa para Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
  • Yam-Trujillo K; Laboratorio de Virología, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
  • Collins MH; Laboratorio de Virología, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
  • Pavia-Ruz N; Laboratorio de Virología, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
  • Ayora-Talavera G; The Hope Clinic of the Emory Vaccine Center, Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Decatur, GA, United States of America.
  • Gonzalez-Olvera G; Laboratorio de Hematología, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
  • Medina-Barreiro A; Laboratorio de Virología, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
  • Bibiano-Marin W; Unidad Colaborativa para Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
  • Lenhart A; Unidad Colaborativa para Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
  • Halloran ME; Unidad Colaborativa para Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
  • Longini I; Entomology Branch, Division of Parasitic Diseases and Malaria, U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Dean N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle WA, United States of America.
  • Waller LA; Department of Biostatistics, University of Washington, Seattle WA, United States of America.
  • Crisp AM; Department of Biostatistics, University of Florida, Gainesville, FL, United States of America.
  • Correa-Morales F; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, United States of America.
  • Palacio-Vargas J; Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University, Atlanta, GA, United States of America.
  • Granja-Perez P; Department of Biostatistics, University of Florida, Gainesville, FL, United States of America.
  • Villanueva S; Centro Nacional de Programas Preventivos y Control de Enfermedades (CENAPRECE) Secretaría de Salud Mexico, Mexico City, Mexico.
  • Delfin-Gonzalez H; Servicios de Salud de Yucatán, Merida, Yucatan, Mexico.
  • Gomez-Dantes H; Servicios de Salud de Yucatán, Merida, Yucatan, Mexico.
  • Manrique-Saide P; Servicios de Salud de Yucatán, Merida, Yucatan, Mexico.
  • Vazquez-Prokopec GM; Unidad Colaborativa para Bioensayos Entomológicos, Campus de Ciencias Biológicas y Agropecuarias, Universidad Autónoma de Yucatán, Mérida, Yucatán, México.
PLoS One ; 19(9): e0310480, 2024.
Article en En | MEDLINE | ID: mdl-39292670
ABSTRACT
Aedes mosquito-borne viruses (ABVs) place a substantial strain on public health resources in the Americas. Vector control of Aedes mosquitoes is an important public health strategy to decrease or prevent spread of ABVs. The ongoing Targeted Indoor Residual Spraying (TIRS) trial is an NIH-sponsored clinical trial to study the efficacy of a novel, proactive vector control technique to prevent dengue virus (DENV), Zika virus (ZIKV), and chikungunya virus (CHIKV) infections in the endemic city of Merida, Yucatan, Mexico. The primary outcome of the trial is laboratory-confirmed ABV infections in neighborhood clusters. Despite the difficulties caused by the COVID-19 pandemic, by early 2021 the TIRS trial completed enrollment of 4,792 children aged 2-15 years in 50 neighborhood clusters which were allocated to control or intervention arms via a covariate-constrained randomization algorithm. Here, we describe the makeup and ABV seroprevalence of participants and mosquito population characteristics in both arms before TIRS administration. Baseline surveys showed similar distribution of age, sex, and socio-economic factors between the arms. Serum samples from 1,399 children were tested by commercially available ELISAs for presence of anti-ABV antibodies. We found that 45.1% of children were seropositive for one or more flaviviruses and 24.0% were seropositive for CHIKV. Of the flavivirus-positive participants, most were positive for ZIKV-neutralizing antibodies by focus reduction neutralization testing which indicated a higher proportion of participants with previous ZIKV than DENV infections within the cohort. Both study arms had statistically similar seroprevalence for all viruses tested, similar socio-demographic compositions, similar levels of Ae. aegypti infestation, and similar observed mosquito susceptibility to insecticides. These findings describe a population with a high rate of previous exposure to ZIKV and lower titers of neutralizing antibodies against DENV serotypes, suggesting susceptibility to future outbreaks of flaviviruses is possible, but proactive vector control may mitigate these risks.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Control de Mosquitos / Aedes / Dengue / Mosquitos Vectores / Insecticidas Límite: Adolescent / Animals / Child / Child, preschool / Female / Humans / Male País/Región como asunto: Mexico Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Control de Mosquitos / Aedes / Dengue / Mosquitos Vectores / Insecticidas Límite: Adolescent / Animals / Child / Child, preschool / Female / Humans / Male País/Región como asunto: Mexico Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos